A bio-nanocapsule containing envelope protein domain III of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection

Tricomponent Immunopotentiating System as a Novel Molecular Design Strategy for Malaria Vaccine Development

(2011) Takeshi Miyata et al.   INFECTION AND IMMUNITY

Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice

(2011) Senji Tafuku et al.   MICROBES AND INFECTION

Nanocapsules incorporating IgG Fc-binding domain derived from Staphylococcus aureus protein A for displaying IgGs on immunosensor chips

(2010) Masumi Iijima et al.   BIOMATERIALS

Adjuvants: no longer a ‘dirty little secret’, but essential key players in vaccines of the future

(2010) Takeshi Arakawa   Expert Review of Vaccines

Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice

(2009) Shailendra Kumar Verma et al.   VACCINE

The coming of age of virus-like particle vaccines

(2008) Gary T. Jennings et al.   BIOLOGICAL CHEMISTRY

Exploiting viral properties for the rational design of modern vaccines

(2008) Gunther Spohn et al.   Expert Review of Vaccines

Specific Protein Delivery to Target Cells by Antibody-displaying Bionanocapsules

(2008) N. Kurata et al.   JOURNAL OF BIOCHEMISTRY